MYLAN 5132 Pill — PURPLE;WHITE CAPSULE, 22mm — Venlafaxine

No photo available

Imprint	MYLAN / 5132
Colour	PURPLE;WHITE
Shape	CAPSULE
Size	22
Strength	VENLAFAXINE 75 mg
Dosage form	Capsule, Extended Release
Manufacturer	UDL Laboratories, Inc.
NDC	51079-135
Schedule	—
Availability	—
Ingredients	VENLAFAXINE HYDROCHLORIDE[VENLAFAXINE]

What does this imprint mean?

The imprint "MYLAN 5132" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Venlafaxine

Uses and warnings

BOXED WARNING: "Antidepressants increased the risk...of suicidal thinking and behavior (suicidality) in children, adolescents and young adults" in short-term studies. Strong warning about monitoring for worsening depression and suicidal thoughts, especially early in treatment or during dose changes. | Serotonin syndrome risk with concurrent use of MAOIs, triptans, tramadol, or other serotonergic drugs; "venlafaxine treatment is associated with sustained increases in blood pressure in some patients"; angle-closure glaucoma risk from pupillary dilation; seizure risk (0.26% incidence reported); hyponatremia, particularly in elderly patients; abnormal bleeding risk when combined with NSAIDs/anticoagulants.

"Venlafaxine tablets are indicated for the treatment of major depressive disorder." Used for patients whose symptoms meet DSM diagnostic criteria for major depression.

Read the full drug profile →